158 filings
Page 7 of 8
8-K
87ogak2
15 Nov 17
Completion of Acquisition or Disposition of Assets
12:00am
8-K/A
b7zff
7 Nov 17
Invitae Reports Double-Digit Sequential Volume and Revenue Growth
12:00am
8-K
qbs743l8yppji
6 Nov 17
Invitae Reports Double-Digit Sequential Volume and Revenue Growth
12:00am
8-K
xdpfm0apl6p7 gm3hw0
6 Oct 17
Invitae Commences Exchange Offer for CombiMatrix Series F Warrants
12:00am
8-K
zu7aqxecuf5y0ezmfnn5
27 Sep 17
Entry into a Material Definitive Agreement
12:00am
8-K
hfmcf9 xnhkjtaxybk
7 Aug 17
Other Events
12:00am
8-K
6ezf8kxe3w
7 Aug 17
Invitae Reports Second Quarter 2017 Results
12:00am
8-K
7n5x1rj64ncj 26n
4 Aug 17
Unregistered Sales of Equity Securities
12:00am
8-K
m83ey
1 Aug 17
Invitae Announces $73.5 Million Private Placement Offering to Fuel Strategic Growth
12:00am
8-K
m1s84n3
1 Aug 17
Other Events
12:00am
8-K
5qm160s8
13 Jun 17
Invitae Acquires CancerGene Connect, Award-Winning Risk Assessment and Family
12:00am
8-K
598zj09syk7o1y0
1 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
uk0c6s jwgfb
19 May 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
947 n9b08
8 May 17
Invitae Exceeds 26,000 Samples Accessioned, Reports Revenue of $10.3 Million and Net Loss of $0.64 Per Share in First Quarter 2017
12:00am
8-K
dd9n3ph
13 Feb 17
Invitae reports revenue of $9.2 million in fourth quarter 2016 and projects strong volume and revenue growth in 2017
12:00am
8-K
54fsus aroagpyq
9 Feb 17
Departure of Directors or Certain Officers
12:00am
8-K
2o6i5vn6xs5u0nmuv
12 Jan 17
Results of Operations and Financial Condition
12:00am
8-K
zcxquoc 55
9 Jan 17
Invitae announces new leadership structure to drive global growth
12:00am
8-K
s3cxspn57hu v0d
6 Jan 17
Invitae acquires patient-centered data company AltaVoice, creating new offerings to
12:00am
8-K
w8ps5rgts6942f 47
17 Nov 16
Invitae Announces Pricing of Public Offering of Common Stock
12:00am